InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: golden flyer post# 290114

Thursday, 08/06/2020 9:35:46 AM

Thursday, August 06, 2020 9:35:46 AM

Post# of 426564

did thero mention at all during CC that sales in Canada were beyond expectations?

Were? Currently it is minimal and Amarin revenue from Canadian sales in next to nothing (top of product supply which has a small marhin).

increasing its peak-year sales estimate for Vascepa to C$275-325 million, from C$200-300 million...

(a) It is a news published on January 6, 2020
(b) HLS expects to reach peak year sales run-rate approximately 4-5 years following product launch ... aka in 2024-25
(c) HLS will pay tiered double digit royalties on net sales. I do not think it will be higher - anytime - than 25%, so it will be 50-60 USD in peak years

Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News